Applications of FDG-PET in Central Nervous System Disorders, An Issue of PET Clinics

1 Edición, Volumen 21-4 - 9 de septiembre de 2026
Última edición
Editores: Andrew B. Newberg, Eric Guedj, Abass Alavi
Idioma: Inglés

In this issue of PET Clinics, guest editors Drs. Andrew B. Newberg, Eric Guedj, and Abass Alavi bring their considerable expertise to the topic of Applications of FDG-PET in… Leer más

Descripción

In this issue of PET Clinics, guest editors Drs. Andrew B. Newberg, Eric Guedj, and Abass Alavi bring their considerable expertise to the topic of Applications of FDG-PET in Central Nervous System Disorders. This issue is the first of four that describes the revolutionary impact of FDG-PET on the day-to-day practice of medicine during the past five decades. Top experts discuss key topics in the areas of Foundations and Normal Brain; Neurodegenerative and Movement Disorders; Epilepsy, Tumors, Structural Damage, Inflammation, and Infection; Psychiatric, Functional, and Subjective Disorders; and Clinical Impact and Future Directions.

Puntos claves

Contains 13 relevant, practice-oriented topics including FDG-PET in cognitive impairment and dementia; FDG-PET in brain tumors; FDG-PET in traumatic brain injury and post-concussive sequelae; FDG-PET in major psychiatric disorders; future directions for FDG-PET in CNS diseases: AI, big data, and network approaches; and more.
Provides in-depth clinical reviews on applications of FDG-PET in central nervous system disorders, offering actionable insights for clinical practice.
Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.

De interès para

Radiology, nuclear medicine

Índice

18F-Fluorodeoxyglucose PET, the Brain, and Other Organs: From the First Human Studies (1976) to 2026
Normal Patterns and Variants in PET Brain Imaging from Childhood to Aging
FDG-PET in Cognitive Impairment and Dementia
FDG-PET in Movement Disorders and Parkinsonian Syndromes

2-[ 18 F]fluoro-2-deoxy-D-glucose PET in Brain Tumors
FDG-PET in Traumatic Brain Injury and Postconcussive Sequelae
Brain [18F]FDG-PET in Encephalitis and Postinfectious Neurocognitive Syndromes

18 F-fluorodeoxyglucose PET in Major Psychiatric Disorders
Brain [18F]FDG-PET in Subjective Cognitive Complaints: From Diagnostic Gap to Neurobiological Insight
Fluorodeoxyglucose PET and Consciousness
Fluorodeoxyglucose PET Scans in the Integrative Medicine Setting
How Fluorine-18-labeled Fluorodeoxyglucose PET Changed Clinical Practice in Central Nervous System Disorders
Future Directions for [18F]FDG PET in Central Nervous System Diseases

Detalles del producto

Edición: 1
Última edición
Volumen: 21-4
Publicado: 9 de septiembre de 2026
Idioma: Inglés

Sobre los editores

Andrew B. Newberg

Editor

Afiliaciones y experiencia

Marcus Institute of Integrative Health Thomas Jefferson University, Villanova, PA, USA

Abass Alavi